Literature DB >> 8311838

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines.

V Bours1, E Dejardin, F Goujon-Letawe, M P Merville, V Castronovo.   

Abstract

NF-kappa B is a pleiotropic transcription factor which controls the expression of many genes and viruses. To date, there is good evidence, but no definitive proof, for its role in tumor formation and development of metastasis. To investigate the possibility that members of the NF-kappa B family could participate in the molecular control of the transformed and invasive phenotype, we examined the expression of these proteins in a variety of human tumor cell lines. The expression of p50, p65, p52 and I kappa B was quantified at the protein level using western immunoblot and mobility shift assay and at the RNA level by northern blot. We observed high expression of the NF-kappa B inhibitor I kappa B in the ovarian carcinoma cell line OVCAR-3 together with constitutive nuclear NF-kappa B activity. We also studied the colon carcinoma cell line HT-29 and its metastatic counterpart HTM-29 and we observed specific expression of the p52 NF-kappa B-related protein in the metastatic cells. Our data confirm that NF-kappa B could be involved in the genesis of a variety of cancers including solid tumors and provide us with interesting models to explore the exact role of these transcription factors in cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311838     DOI: 10.1016/0006-2952(94)90448-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  42 in total

1.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis.

Authors:  Bao-Song Zhu; Chun-Gen Xing; Fang Lin; Xiao-Qing Fan; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 3.  Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis.

Authors:  Ryan W Dellinger; Feng Liu-Smith; Frank L Meyskens
Journal:  J Photochem Photobiol B       Date:  2014-06-20       Impact factor: 6.252

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

6.  The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

Authors:  C Chen; L C Edelstein; C Gélinas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD).

Authors:  S G Maher; C E M Condron; D J Bouchier-Hayes; D M Toomey
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 8.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

9.  Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.

Authors:  Zhe Wang; Baochun Zhang; Liqun Yang; Jane Ding; Han-Fei Ding
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

10.  The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population.

Authors:  Yue Wang; Libo Chen; Liming Pan; Jinru Xue; Haixiang Yu
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.